A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Malignant Neoplasm|Breast Cancer|Ovarian Cancer|Homologous Recombination Deficiency|Prostate Cancer|Pancreatic Cancer
Interventions: DRUG: AMXI-5001:Dose Escalation Phase I|DRUG: AMXI-5001:Dose Expansion Phase II
Sponsor: AtlasMedx, Incorporated